| PROTALIX BIOTHERAP.DL-,01 |
| USA |
| Gesundheit |
| US74365A3095 / A2PWSL |
| PBDA (Frankfurt) |
| FRA:PBDA, ETR:PBDA, PBDA:GR |
| - |
| http://protalix.com/ |
|
Protalix Biotherapeutics Inc. is a biopharmaceutical company focused on developing and manufacturing therapeutic proteins using its proprietary plant cell-based expression system. This innovative platform allows for the production of recombinant prot..
>Volltext.. |
| 152.49 Mio. EUR |
| 133.43 Mio. EUR |
| 45.17 Mio. EUR |
| -3.46 Mio. EUR |
| -5.66 Mio. EUR |
| -0.07 EUR |
| 7.13 Mio. EUR |
| 13.17 Mio. EUR |
| -10.27 Mio. EUR |
| 1.17 |
| -12.94% |
| -298.53% |
| - |
| - |
| - |
| - |
| PROTALIX |
| 08.04.26 |
|